https://www.imcdmx.com/our-knowledge/trends/formulating-success-how-excipient-providers-are-enabling-advanced-glp-1-therapie-MCT7SUC33DFVEP7PS2EQBEYOKKNU2026-06-29T15:10:04.000Z